ROIV is trading 4.3% up at $30.55 in pre-market action, showing strength despite a lack of immediate fundamental catalysts.
- Shares are rebounding from a previous close of $29.29 after a period of stagnant trading last week.
- No new company-specific headlines, earnings reports, or clinical data have been released to account for the price action.
- The move comes as broader U.S. futures trend lower, suggesting the gains may be driven by positioning or order flow ahead of the regular session.